ArrowMark Colorado Holdings LLC 13D and 13G filings for Revance Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 1:29 pm Sale |
2020-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
ArrowMark Colorado Holdings LLC | 2,964,135 4.500% |
-1,876,501 (-38.77%) |
Filing |